spacer
home > epc > winter 2001 > improving clinical trial management - moving shipping logistics online
PUBLICATIONS
European Pharmaceutical Contractor

Improving Clinical Trial Management - Moving Shipping Logistics Online

Clinical trials are both a major financial investment and a risk for pharmaceutical and biotechnology companies. The Boston Consulting Group estimated that when interest and drug failure costs are taken into consideration, the cost of developing a new drug could be as high as US$500 million (1). This cost is primarily driven by the increasingly stringent requirement for companies to satisfy relevant regulatory authorities that the drug being developed is both effective and safe for use in the patient populations for whom it is intended. Clinical trials undertaken to provide this reassurance can vary from single centre studies right up to the multi-centre, global studies with thousands of patients undergoing treatment for several years. This increased tendency for long-term global trials is driven by numerous aspects, including the following:

The need to enrol appropriately 'treatment-naive' patients in a heavily medicalised world

The need to push for subtle improvements over existing therapy

The need to encompass 'outcomes' issues and pharmacoeconomic aspects

The need to check for rare interactions and adverse events

The need to provide data involving populations/countries included in launch plans

The need to provide persuasive evidence to authorities no longer confined to purely medical assessment

The overall increased regulatory hurdles have resulted in a drug development time of 15 years being considered average - from the time of a new chemical entity's discovery in the laboratory to the eventual marketing approval and granting of a product licence (2).


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

Banner of CRS on Samedan
spacer
By Dr Drew Kilpatrick, Associate Director of Project Management at Inveresk Research and Peter Crespin of 'The Writers Bureau

Dr Drew Kilpatrick is Associate Director of Project Management at Inveresk Research - a global CRO providing preclinical and clinical support to the pharmaceutical industry. He has extensive clinical research and project management experience gained in both CROs and pharmaceutical companies.

Peter Crespin established 'The Writers Bureau' in 1995 to provide medical and marketing communications consultancy services. He has extensive industry and agency experience, specialising in international programmes, and today serves most of the big agencies as well as direct service to pharma clients.

spacer
Dr Drew Kilpatrick
spacer
spacer
spacer
Peter Crespin
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

2012 BIO International Convention

18-21 June 2012, Boston, Massachusetts

Connect, partner and innovate at the 2012 BIO International Convention, June 18-21, Boston, Mass. Network with 15,000+ global biotech leaders in the BIO Business Forum, Exhibition and Programme.
More info >>

 
News and Press Releases

Topa Thermal Packaging introduces innovative pallet shipper

Topa Thermal Packaging has developed an innovative packaging for manufacturers that transport large quantities of temperature-sensitive products by road and air transport, such as vaccines and medicines. The ‘ClimateBox™ half PAG Pallet Shipper’ delivers significant time and cost savings, thanks to an efficient filling system.
More info >>

 

 

Buy Atrovent Online no prescription Buy Symbicort Online no prescription Buy Flovent Online no prescription Buy Flonase Online no prescription Buy Rhinocort Online no prescription Buy Allegra Online no prescription Buy Advair Online no prescription Buy Combivent Online no prescription Buy Astelin Online no prescription Buy Spiriva Online no prescription Buy Ventolin Online no prescription
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement
.